AXL targeting reduces fibrosis development in experimental unilateral ureteral obstruction

Lea Landolt1, Jessica Furriol2, Janka Babickova1

  • 1Department of Clinical Medicine, University of Bergen, Bergen, Norway.

Insights

AXL receptor inhibition with bemcentinib reduced kidney fibrosis and inflammation in mice with unilateral ureteral obstruction. This suggests AXL receptor tyrosine kinase (RTK) is a promising therapeutic target for treating kidney fibrosis.

Area of Science:

  • Nephrology
  • Molecular Biology
  • Pharmacology

Background:

  • Renal fibrosis is a major cause of kidney disease progression.
  • Epithelial-to-mesenchymal transition (EMT) and inflammation are key drivers of renal fibrosis.
  • AXL receptor tyrosine kinase (RTK) signaling is implicated in EMT and inflammation.

Purpose of the Study:

  • To investigate the therapeutic potential of AXL inhibition in a mouse model of kidney fibrosis.
  • To evaluate the effects of bemcentinib, an AXL inhibitor, on fibrosis and inflammation markers following unilateral ureteral obstruction (UUO).

Main Methods:

  • Unilateral ureteral obstruction (UUO) model in C57BL/6 mice.
  • Treatment groups included bemcentinib, ACE inhibitor (ACEI), combined ACEI and bemcentinib, and vehicle control.
  • Kidney tissues analyzed via immunohistochemistry (IHC), western blot, ELISA, Sirius Red staining, hydroxyproline quantification, and RNA sequencing.

Main Results:

  • Bemcentinib treatment significantly reduced kidney fibrosis, as evidenced by Sirius Red staining and hydroxyproline levels.
  • AXL inhibition decreased markers of (partial) epithelial-to-mesenchymal transition (EMT), including Vimentin (VIM), alpha smooth muscle actin (αSMA), and key EMT regulators.
  • Bemcentinib treatment also reduced inflammatory infiltrates, indicated by lower F4/80 positive cells and inflammatory chemokines (MCP1, MCP3, MCP5, TARC).

Conclusions:

  • AXL receptor tyrosine kinase (RTK) signaling blockade with bemcentinib effectively ameliorates kidney fibrosis and associated inflammation.
  • AXL RTK inhibition demonstrates significant therapeutic potential for managing kidney fibrosis.
  • Targeting the AXL RTK pathway offers a promising strategy for pharmacologic intervention in kidney fibrosis.

Related Concept Videos

Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
743
Reducing Line Loss01:18

Reducing Line Loss

In a three-phase circuit, line loss is an indicator of energy dissipated as heat due to the resistance of transmission lines. To address this, incorporating transformers into the system—a step-up transformer at the source and a step-down transformer at the load—is a strategic solution. Two three-phase transformers are introduced to improve this.
With a step-up transformer at the source, the voltage is increased, thereby reducing the current in the transmission lines since power loss in...
372
Methods of reducing fever01:22

Methods of reducing fever

The signs and symptoms of fever include hot and dry skin, flushed face, thirst, muscle aches, anorexia, headache, tachycardia, tachypnea, and fatigue. Elevated body temperature is reduced using two methods: pharmacological and nonpharmacological. Proper identification and treatment of the root cause of a fever is of utmost importance.
Pharmacological Methods of Reducing Fever:
1.3K
Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
489
Chronic Obstructive Pulmonary Disease01:22

Chronic Obstructive Pulmonary Disease

COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
2.4K
Design Example: Measuring Distance Between Two Points with Obstructions01:10

Design Example: Measuring Distance Between Two Points with Obstructions

When measuring distances in areas with physical obstructions, such as a lake in a field, surveyors must employ techniques to calculate accurate lengths without direct line measurements. One effective method is the offset technique, which allows for precise distance estimation over inaccessible stretches.In this scenario, a surveyor must measure a side of an area that crosses a lake. Since the measuring tape cannot span the lake, the surveyor begins by establishing a baseline that aligns with...
393